These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16257505)

  • 21. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
    Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of Parkinson's disease dementia: association with aging and visual hallucination.
    Kitayama M; Wada-Isoe K; Nakaso K; Irizawa Y; Nakashima K
    Acta Neurol Scand; 2007 Sep; 116(3):190-5. PubMed ID: 17714333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia.
    Sanchez-Castaneda C; Rene R; Ramirez-Ruiz B; Campdelacreu J; Gascon J; Falcon C; Calopa M; Jauma S; Juncadella M; Junque C
    Mov Disord; 2009 Sep; 24(12):1740-6. PubMed ID: 19569130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lewy body dementia.
    Hanson JC; Lippa CF
    Int Rev Neurobiol; 2009; 84():215-28. PubMed ID: 19501720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The morphological basis of mental dysfunction in Parkinson's disease.
    Jellinger KA
    J Neurol Sci; 2006 Oct; 248(1-2):167-72. PubMed ID: 16797594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction.
    Kösel S; Egensperger R; Schnopp NM; Graeber MB
    Mov Disord; 1997 Sep; 12(5):639-45. PubMed ID: 9380043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.
    Ferrer I; Perez E; Dalfó E; Barrachina M
    Neurosci Lett; 2007 Mar; 415(3):205-9. PubMed ID: 17284347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.
    Greffard S; Verny M; Bonnet AM; Beinis JY; Gallinari C; Meaume S; Piette F; Hauw JJ; Duyckaerts C
    Arch Neurol; 2006 Apr; 63(4):584-8. PubMed ID: 16606773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies.
    Mollenhauer B; Steinacker P; Bahn E; Bibl M; Brechlin P; Schlossmacher MG; Locascio JJ; Wiltfang J; Kretzschmar HA; Poser S; Trenkwalder C; Otto M
    Neurodegener Dis; 2007; 4(5):366-75. PubMed ID: 17622779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroinvasive Nocardia asteroides GUH-2 induces apoptosis in the substantia nigra in vivo and dopaminergic cells in vitro.
    Tam S; Barry DP; Beaman L; Beaman BL
    Exp Neurol; 2002 Oct; 177(2):453-60. PubMed ID: 12429191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders].
    Escamilla-Sevilla F; Pérez-Navarro MJ; Muñoz-Pasadas M; Ortega-Léon T; Gallego-Peinado M; Cabello-García D; Gómez Río M; Ortega-Moreno A; Carnero-Pardo C; Rebollo-Aguirre AC; Mínguez-Castellanos A
    Neurologia; 2009 Apr; 24(3):170-6. PubMed ID: 19418293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reappraisal of a consecutive autopsy series of patients with primary degenerative dementia: Lewy-related pathology.
    Oinas M; Sulkava R; Polvikoski T; Kalimo H; Paetau A
    APMIS; 2007 Jul; 115(7):820-7. PubMed ID: 17614849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease.
    Ransmayr GN; Holliger S; Schletterer K; Heidler H; Deibl M; Poewe W; Madersbacher H; Kiss G
    Neurology; 2008 Jan; 70(4):299-303. PubMed ID: 18209204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitro.
    Ono K; Noguchi-Shinohara M; Yoshita M; Naiki H; Yamada M
    Exp Neurol; 2007 Feb; 203(2):579-83. PubMed ID: 17011551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control.
    Koziorowski D; Friedman A; Arosio P; Santambrogio P; Dziewulska D
    Parkinsonism Relat Disord; 2007 May; 13(4):214-8. PubMed ID: 17275395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dementia with Lewy bodies and reduced dopamine transporter binding indicates significant acetylcholine deficiency].
    Förstl H; Gratz S; Hahn U; Schwarz J; Jarnig M
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S11-4. PubMed ID: 18437636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies.
    Yamamoto R; Iseki E; Murayama N; Minegishi M; Marui W; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
    J Neurol Sci; 2006 Jul; 246(1-2):95-101. PubMed ID: 16624323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-dopa-responsive movement disorder caused by Nocardia asteroides localized in the brains of mice.
    Kohbata S; Beaman BL
    Infect Immun; 1991 Jan; 59(1):181-91. PubMed ID: 1670928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study.
    Louis ED; Honig LS; Vonsattel JP; Maraganore DM; Borden S; Moskowitz CB
    Arch Neurol; 2005 Jun; 62(6):1004-7. PubMed ID: 15956174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.